- ►pipex.com [PDF] RR Holman, KI Thorne, AJ Farmer, MJ Davies, … - New England Journal of Medicine, 2007 - content.nejm.org From the Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and
Metabolism (RRH, KIT, AJF, JFK, SP, JCL) and the Department of Primary Health
Care (AJF), University of Oxford, Oxford; and the Department of Cardiovas- ... Cited by 137 - Related articles - BL Direct - All 12 versions
A Philis-Tsimikas, G Charpentier, P Clauson, … - Clinical therapeutics, 2006 - Elsevier This 20-week, multicenter, randomized, open-label, 3-arm, parallel-group trial
was conducted at 91 centers across Europe and the United States. Men and women
were eligible for participation if they were aged ≥18 years, had a body ... Cited by 85 - Related articles - All 4 versions
LF Meneghini, KH Rosenberg, C Koenen, MJ … - Diabetes Obes Metab, 2007 - journals.pcommed.com 1Diabetes Research Institute, University of Miami Miller School of Medicine,
Miami, FL, USA 2Epidemiology, Novo Nordisk A/S, DK-2880 Bagsværd, Denmark
3Medical & Science, Novo Nordisk A/S, DK-2880, Bagsværd, Denmark 4Center ... Cited by 54 - Related articles - View as HTML - All 4 versions
T Heise, TR Pieber - Diabetes Obes Metab, 2007 - journals.pcommed.com While the advantages of the two basal insulin analogues, glargine and detemir,
over neutral protamine Hagedorn are well established, the relative merit of the
two compared with each other has been a matter of some controversy. The two ... Cited by 46 - Related articles - View as HTML - All 4 versions
A Dornhorst, HJ Luddeke, S Sreenan, C … - International journal of clinical practice, 2007 - interscience.wiley.com PREDICTIVE TM (Predictable Results and Experience in Diabetes through
Intensification and Control to Target: An International Variability Evaluation)
is a large, multi-national, open-label, prospective, observational study ... Cited by 34 - Related articles - BL Direct - All 5 versions
- Free from Publisher J Rosenstock, AJ Ahmann, G Colon, J Scism- … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—Baseline A1C was similar (PPT 8.8%; BBT 8.9%; P = 0.598). At week 24,
A1C was lower with BBT (6.78 vs. 6.95%, P = 0.021). A1C was reduced
significantly from baseline for both therapies (P < 0.0001). The difference ... Cited by 29 - Related articles - BL Direct - All 5 versions
PC Bartley, M Bogoev, J Larsen, A Philotheou - Diabetic Medicine, 2008 - pubmedcentral.nih.gov This study was published as an abstract at EASD 2007. Bartley P, Bogoev M,
Larsen J, Tamer SC, Philotheou A. Superior glycaemic control, less nocturnal
hypoglycaemia and less weight gain with insulin detemir relative to NPH ... Cited by 24 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org M Riddle, J Frias, B Zhang, H Maier, C Brown, … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS— In a 16-week, double-blind, placebo-controlled
study, 212 patients using insulin glargine with or without oral antidiabetes
agents (OAs) were randomized to addition of pramlintide (60 or 120 μg ... Cited by 25 - Related articles - BL Direct - All 5 versions
